Clinical Trial: Mapping analysis of disease-specific quality of life measurement and preference-based measurement in adult patients with attention deficit hyperactivity disorder (Japan)

Tokyo, Oct. 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063152) titled 'Mapping analysis of disease-specific quality of life measurement and preference-based measurement in adult patients with attention deficit hyperactivity disorder' on Oct. 4.

Study Type: Observational

Primary Sponsor: Institute - Otsuka Pharmaceuticals Co., Ltd

Condition: Condition - Attention deficit/hyper activity disorder Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - Conduct a questionnaire survey focusing on adults with attention deficit hyperactivity disorder (ADHD) and mapping analysis using the Adult ADHD Quality of Life Scale (AAQoL), a disease-specific qu...